News

The latest from Lumen

Antibody

Project includes funding for preliminary engineering work on facility to manufacture over 1 billion doses per year

CMO

Experienced Industry Leader to Advance Lumen’s Clinical Pipeline

Devel

Lead therapeutic candidates for widespread enteric diseases including C. difficile, norovirus, and traveler’s diarrhea

Article Image

August 26th, 2020
Genetic Engineering & Biotechnology News

Phages

Antibacterial campaigns may simply requisition the organisms’ battle-tested cell-wall-breaching enzymes

Lumen scientist

Lumen is chasing the $1.5 billion market for natural colorants with technology that uses Spirulina.